Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun 4;41(6):124-131.
doi: 10.14745/ccdr.v41i06a02.

Hantavirus pulmonary syndrome in Canada: An overview of clinical features, diagnostics, epidemiology and prevention

Affiliations

Hantavirus pulmonary syndrome in Canada: An overview of clinical features, diagnostics, epidemiology and prevention

M A Drebot et al. Can Commun Dis Rep. .

Abstract

Hantavirus pulmonary syndrome is a disease caused by the inhalation of excreta from infected deer mice. In Canada, the majority of hantavirus pulmonary syndrome cases occur in the western provinces of British Columbia, Alberta, Saskatchewan and Manitoba and the primary cause of the illness is the Sin Nombre virus. Only one case of hantavirus pulmonary syndrome has been documented in eastern Canada (Québec); however, Sin Nombre virus-infected deer mice have been identified across the country. Although cases are rare (yearly case numbers range from zero to 13 and the total number of confirmed cases in Canada now total 109), the mortality rate among infected individuals is approximately 30%. The majority of cases occur in the spring and early summer indicating seasonally-associated risk factors for viral exposure. In 2013 and 2014, a substantial increase in the number of hantavirus pulmonary syndrome cases was identified; however the cause remains unclear. No antivirals or vaccines are currently available and treatment is supportive. Public education, rodent control and the use of personal protective measures are key to avoid infections in at-risk populations.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None.

Figures

Figure 1
Figure 1
Illustration of the typical cycle of transmission of hantaviruses
Figure 2
Figure 2
Distribution and total number of hantavirus pulmonary syndrome cases (n=109) reported in Canada, 1989 to 2014
Figure 3
Figure 3
Seasonal distribution of hantavirus pulmonary syndrome cases (HPS) in Canada (n=109)

References

    1. Pan-American Health Organization. Hantaviruses in the Americas: Guidelines for prevention, diagnosis, treatment, prevention and control. Washington, US: PAHO, Technical Paper 47;1999.
    1. Klein SL, Calisher CH. Emergence and persistence of hantaviruses. Curr Top Microbiol Immunol 2007;315:217–52. 10.1007/978-3-540-70962-6_10 - DOI - PubMed
    1. Drebot MA, Artsob H, Werker D. Hantavirus pulmonary syndrome in Canada, 1989-1999. Can Commun Dis Rep 2000. Apr;26(8):65–9. - PubMed
    1. Drebot MA, Safronetz D. Sin Nombre Virus. In: Dongyou Liu, editor. Molecular detection of human viral pathogens. Boca Raton, FL: CRC Press, Taylor and Francis Group; 2011. p. 691-701.
    1. Graziano KL, Tempest B. Hantavirus pulmonary syndrome: a zebra worth knowing. Am Fam Physician 2002. Sep;66(6):1015–20. - PubMed